SynthesisCanadian journal of anaesthesia = Journal canadien d'anesthesie2026
Effect of therapeutic interventions combined with lung-protective ventilation on long-term mortality of patients with acute respiratory distress syndrome: a network meta-analysis.
Synthesis in Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Beyond network rankings: caution in long-term acute respiratory distress syndrome survival interpretation.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2026Article
- Lung-Protective Effect of Alveolar Recruitment Maneuvers in Children with Right Vertical Infra-Axillary Thoracotomy for Repair of Congenital Heart Disease.Children (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeLong-term effects of ventilatory strategies/adjunctive therapies received in the intensive care unit on mortality of patients with acute respiratory distress syndrome (ARDS) is uncertain. To explore 180-day mortality in adult patients with ARDS, we conducted a network meta-analysis (NMA) comparing the effects of various prespecified interventions added to lung-protective ventilation (LPV). SOURCE: We systematically searched six databases on 8 November 2024. Two reviewers independently identified eligible randomized clinical trials with published Kaplan-Meier curves, exploring prespecified interventions combined with LPV and LPV alone. Data were synthesized with NMA of survival curves using Bayesian random effects fractional polynomial models. PRINCIPAL
findingsTwenty-two trials with 8,653 participants assessed six different interventions added to LPV (open lung strategy, neuromuscular blockade [NMBA], corticosteroids, high-frequency oscillatory ventilation [HFOV], prone positioning, and venovenous extracorporeal membrane oxygenation [VV ECMO]), compared with LPV alone. We did not include inhaled pulmonary vasodilator trials. The primary NMA computed survival probability of each intervention on the basis of survival probability of LPV alone at 180 days (0.52; 95% credible interval, 0.49 to 0.55). Compared with LPV alone, 1) the evidence suggests prone positioning results in a reduction in 180-day mortality; 2) an open lung strategy does not reduce 180-day mortality; 3) VV ECMO, NMBA, and corticosteroids may reduce 180-day mortality (very uncertain); and 4) HFOV may increase 180-day mortality (very uncertain). We extrapolated reported mortalities to 180-day mortality in 16 trials, where there might be discrepancy between raw and extrapolated numbers in event rate.
conclusionsProne positioning may improve long-term mortality in patients with ARDS. STUDY REGISTRATION: PROSPERO ( CRD42019131849 ); first submitted 26 April 2019.
Indexed as
Identifiers
41781628What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.